Literature DB >> 16186404

Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families.

Patrick Concannon1, Henry A Erlich, Cecile Julier, Grant Morahan, Jørn Nerup, Flemming Pociot, John A Todd, Stephen S Rich.   

Abstract

Type 1 diabetes is a common, multifactorial disease with strong familial clustering (genetic risk ratio [lambda(S)] approximately 15). Approximately 40% of the familial aggregation of type 1 diabetes can be attributed to allelic variation of HLA loci in the major histocompatibility complex on chromosome 6p21 (locus-specific lambda(S) approximately 3). Three other disease susceptibility loci have been clearly demonstrated based on their direct effect on risk, INS (chromosome 11p15, allelic odds ratio [OR] approximately 1.9), CTLA4 (chromosome 2q33, allelic OR approximately 1.2), and PTPN22 (chromosome 1p13, allelic OR approximately 1.7). However, a large proportion of type 1 diabetes clustering remains unexplained. We report here on a combined linkage analysis of four datasets, three previously published genome scans, and one new genome scan of 254 families, which were consolidated through an international consortium for type 1 diabetes genetic studies (www.t1dgc.org) and provided a total sample of 1,435 families with 1,636 affected sibpairs. In addition to the HLA region (nominal P = 2.0 x 10(-52)), nine non-HLA-linked regions showed some evidence of linkage to type 1 diabetes (nominal P < 0.01), including three at (or near) genome-wide significance (P < 0.05): 2q31-q33, 10p14-q11, and 16q22-q24. In addition, after taking into account the linkage at the 6p21 (HLA) region, there was evidence supporting linkage for the 6q21 region (empiric P < 10(-4)). More than 80% of the genome could be excluded as harboring type 1 diabetes susceptibility genes of modest effect (lambda(S) > or = 1.3) that could be detected by linkage. This study represents one of the largest linkage studies ever performed for any common disease. The results demonstrate some consistency emerging for the existence of susceptibility loci on chromosomes 2q31-q33, 6q21, 10p14-q11, and 16q22-q24 but diminished support for some previously reported locations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186404     DOI: 10.2337/diabetes.54.10.2995

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  84 in total

1.  Replication and further characterization of a Type 1 diabetes-associated locus at the telomeric end of the major histocompatibility complex.

Authors:  Erin E Baschal; Suparna A Sarkar; Theresa A Boyle; Janet C Siebert; Jean M Jasinski; Katharine R Grabek; Taylor K Armstrong; Sunanda R Babu; Pamela R Fain; Andrea K Steck; Marian J Rewers; George S Eisenbarth
Journal:  J Diabetes       Date:  2011-09       Impact factor: 4.006

Review 2.  Epidemiology of type 1 diabetes.

Authors:  David M Maahs; Nancy A West; Jean M Lawrence; Elizabeth J Mayer-Davis
Journal:  Endocrinol Metab Clin North Am       Date:  2010-09       Impact factor: 4.741

3.  HLA-DRB1 the notorious gene in the mosaic of autoimmunity.

Authors:  María-Teresa Arango; Carlo Perricone; Shaye Kivity; Enrica Cipriano; Fulvia Ceccarelli; Guido Valesini; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

4.  DNA methylation near the INS gene is associated with INS genetic variation (rs689) and type 1 diabetes in the Diabetes Autoimmunity Study in the Young.

Authors:  Patrick M Carry; Lauren A Vanderlinden; Randi K Johnson; Fran Dong; Andrea K Steck; Brigitte I Frohnert; Marian Rewers; Ivana V Yang; Katerina Kechris; Jill M Norris
Journal:  Pediatr Diabetes       Date:  2020-02-28       Impact factor: 4.866

5.  Next-Generation HLA Sequence Analysis Uncovers Seven HLA-DQ Amino Acid Residues and Six Motifs Resistant to Childhood Type 1 Diabetes.

Authors:  Lue Ping Zhao; George K Papadopoulos; William W Kwok; Antonis K Moustakas; George P Bondinas; Annelie Carlsson; Helena Elding Larsson; Johnny Ludvigsson; Claude Marcus; Ulf Samuelsson; Ruihan Wang; Chul-Woo Pyo; Wyatt C Nelson; Daniel E Geraghty; Åke Lernmark
Journal:  Diabetes       Date:  2020-08-31       Impact factor: 9.461

6.  MHC-environment interactions leading to type 1 diabetes: feasibility of an analysis of HLA DR-DQ alleles in relation to manifestation periods and dates of birth.

Authors:  K Badenhoop; H Kahles; C Seidl; O Kordonouri; E R Lopez; M Walter; S Rosinger; A Ziegler; B O Böhm
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

7.  Effect of linkage status of affected sib-pairs on the search for novel type 1 diabetes susceptibility genes in the HLA complex.

Authors:  G Morahan; M Mehta; E McKinnon; I James
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

8.  Association analysis of SNPs in the IL4R locus with type I diabetes.

Authors:  H A Erlich; K Lohman; S J Mack; A M Valdes; C Julier; D Mirel; J A Noble; G E Morahan; S S Rich
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

9.  Overview of the Rapid Response data.

Authors:  W M Brown; J J Pierce; J E Hilner; L H Perdue; K Lohman; L Lu; P I W de Bakker; K Irenze; L Ziaugra; D B Mirel
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

10.  Association analyses of the vitamin D receptor gene in 1654 families with type I diabetes.

Authors:  H Kahles; G Morahan; J A Todd; K Badenhoop
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.